ePoster 51
Gynecology (case) 1
October 21 (Sat) 8:30 - 9:20 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P51-1Gynecology (case) A case of endometrial carcinoma that rapidly developed metastases of a neuroendocrine carcinoma component with BRAF-fusion during fertility preservation treatment
[Speaker] Yoko Kashima:1 1:Obsterics&Gynecology, Kindai University |
|
P51-2Gynecology (case) A case of clear cell carcinoma arising from adenomyotic cyst
[Speaker] Yoshito Morishita:1 1:Department of Obstetrics and Gynecology, Faculty of Medicine, Kyushu University |
|
P51-3Gynecology (case) A case of low-grade endometrial stromal sarcoma treated with letrozole
[Speaker] Yusuke Taira:1 1:Department of Obstetrics and Gynecology, University of the Ryukyus |
|
P51-4Gynecology (case) Successful monotherapy with autologous formalin-fixed tumor vaccine for a stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatment
[Speaker] Tadao Ohno:1 1:Headquarter, Cell-Medicine, Inc. |
|
P51-5Gynecology (case) A case of uterine cancer survivable by multidisciplinary treatment including chemotherapy and mechanical ventilation
[Speaker] Fumio Asano:1 1:Department of Obstetrics and Gynecology, Faculty of Medicine, Kyorin University |
|
P51-6Gynecology (case) A case of advanced cervical cancer with BRCA1 gene mutation
[Speaker] Yuu Hayata:1 1:Kagawa Prefectural Central Hospital |
|
P51-7Gynecology (case) Metastatic pancreatic carcinoma to the uterine cervix, vNOTES contributed to the diagnosis: A case report
[Speaker] Yu Kamishita:1 1:Obstetrics and Gynecology, SAGA-KEN MEDICAL CENTRE KOSEIKAN |
ePoster 52
Gynecology (case) 2
October 21 (Sat) 9:20 - 10:10 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P52-1Gynecology (case) The case of high-grade serous ovarian carcinoma with GOPC-ROS1 fusion gene
[Speaker] Chiharu Wada:1 1:Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University |
|
P52-2Gynecology (case) A case of a malignant tumor arising from an ovarian mature teratoma that was diagnosed 17 years ago
[Speaker] Akiho Nagayama:1 1:Chibune General Hospital |
|
P52-3Gynecology (case) A case of synchronous primary ovarian mucinous borderline tumor and low-grade appendiceal mucinous neoplasm
[Speaker] Yoshiyuki Takahashi:1 1:Okinawa Prefectural Chubu Hospital |
|
P52-4Gynecology (case) A case of malignant transformation arising from ovarian mature teratoma with G-CSF production
[Speaker] Iemasa Koh:1 1:Obstetrics and gynecology, Hiroshima University |
|
P52-5Gynecology (case) A case of mucinous cystic tumor with mural nodule (anaplastic carcinoma)
[Speaker] Eijiro Uchikura:1 1:Obsterics and gynecology, Graduate School of Medicine, Osaka Metropolitan University |
|
P52-6Gynecology (case) A case of leiomyosarcoma of unknown primary diagnosed by laparoscopic surgery
[Speaker] Rina Shibata:1 1:Department of Obstetrics & Gynecology, Toyota Memorial Hospital |
|
P52-7Gynecology (case) A case report of nearly single bevacizumab administration maintained long term PR for an elderly patient with peritoneal dissemination from fallopian tube cancer
[Speaker] Masahiro Tateishi:1 1:Department of Surgery, Chiyoda Hospital |
ePoster 53
Supportive care, Patient support
October 21 (Sat) 10:30 - 11:20 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P53-1Supportive care, Patient support Clinical experience of patients with solid cancer complicated takotsubo cardiomyopathy
[Speaker] Takayuki Kuga:1 1:Department of Surgery, Nagato General Hospital |
|
P53-2Supportive care, Patient support Investigation of the long-term effect of a ketogenic diet for cancer using inverse probability of treatment weighting (IPTW)
[Speaker] Ryuichirou Egashira:1 1:Department of Advanced Hybrid Meidicine, Graduate School of Medicine, Osaka University |
|
P53-3Supportive care, Patient support Simple categorization of malignant bowel obstruction for palliative surgery. Strategy and results
[Speaker] Yoshiaki Maeda:1 1:Department GI. Surgery, National Hospital Organization -Hokkaido Cancer Center- |
|
P53-4Supportive care, Patient support Investigation of CART for cancer patients in our hospital
[Speaker] Shin Kibe:1 1:Surgery, Sadakouseikai Sada Hospital |
|
P53-5Supportive care, Patient support Advance care planning for patients with relapsed/refractory hematopoietic malignancies in the treatment process
[Speaker] Kazuko Akashi:1 1:Health Sciences, Graduate School, The University of Tokushima |
|
P53-6Supportive care, Patient support A Clinical Psychological Analysis of the Experiential Process of Working Cancer Patients and the Appropriateness of Support
[Speaker] Chika Uetake:1 1:Division of Clinical Psychology, Graduate school of Education, The University of Tokyo |
|
P53-7Supportive care, Patient support How to Promote the Use of "Cancer Navigators" A Nationwide Survey of Outpatient Nurse Managers and Outpatient Nurses at the Cancer Care Hospitals
[Speaker] Arisa Tanaka:1,2 1:Palliative Medicine, Graduate School of Medicine, Saitama Medical University, 2:System Development Department, PERSOL EXCEL HR Partners, Inc. |
ePoster 54
Basic research
October 21 (Sat) 11:20 - 12:05 ePoster Booth 1 | Pacifico Yokohama Exhibition Hall AB
|
P54-1Basic research Development of new therapeutic agents for malignant meningiomas: potentials of curcumin analogs (Part 2)
[Speaker] Anna Terasawa:1 1:Department Clinical Oncology, Graduate School of Medicine, Akita University |
|
P54-2Basic research Evaluation of therapeutic targets focusing on ion channels, TRPV2 and SLC12A2, in esophageal adenocarcinoma stem cells
[Speaker] Naosuke Nakamichi:1 1:Digestive surgery, Kyoto Prefectural University of Medicine |
|
P54-3Basic research Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose
[Speaker] Taichi Yoshida:1 1:Clinical Oncology, Graduate School of Medicine, Akita University |
|
P54-4Basic research Exosomal microRNA derived from lenvatinib-resistant hepatocellular carcinoma promotes malignant behavior by inducing M2 polarized macrophages via regulating Nrf2 signaling pathway
[Speaker] Yuhei Waki:1 1:Department of Digestive and Pediatrics Surgery, Graduate School, The University of Tokushima |
|
P54-5Basic research A novel high-intensity focused ultrasound (HIFU) treatment has a strong abscopal effect on in vivo mouse models
[Speaker] Rui Tada:1,2 1:Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2:Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences |
|
P54-6Basic research Preliminary Study of Gadoteridol-Entrapped Water-in-Oil-in-Water Emulsion as Novel Gadolinium Carrier for Neutron Capture Therapy in Hepatic Cancer Model
[Speaker] Hironobu Yanagie:1,2,3 1:Institute of Engineering Innovation, Graduate School of Engineering, The University of Tokyo, 2:Cooperative Unit of Medicine & Engineering, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 3:Research Institute of Healthy Living, Niigata University of Pharmacy & Applied Life Sciences |
ePoster 55
Pharmacology 4
October 21 (Sat) 8:30 - 9:15 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P55-1Pharmacology Early experience of cancer patient support and pharmacist intervention using ePRO in anticancer drug treatment
[Speaker] Takaaki Kiuchi:1 1:JR Tokyo General Hospital |
|
P55-2Pharmacology Can oxisaliplatin be administered to a patient with a history of oxisaliplatin use ?
[Speaker] Risa Tsurumi:1 1:Pharmacy department, Furanokyokai Hospital |
|
P55-3Pharmacology Utility of Inflammatory and Nutritional Markers as irAE Predictors in Pembrolizumab
[Speaker] Yosuke Maki:1 1:Pharmaceutical department, Kokura Medical Center |
|
P55-4Pharmacology About mGPS at the start of chemotherapy and the duration of treatment continuity
[Speaker] Sayo Nakade:1 1:Department of pharmacy, Yao Tokushukai General Hospital |
|
P55-5Pharmacology A Study of the Usefulness for Fosnetupitant in Combination Chemotherapy with Carboplatin
[Speaker] Nobukazu Tomita:1 1:Department of Pharmacy, Konan Kosei Hospital |
|
P55-6Pharmacology Effect of PBPM in Outpatient Chemotherapy
[Speaker] Akiya Mori:1 1:Department of pharmacy, Suzuka General Hospital |
ePoster 56
Pharmacology 5
October 21 (Sat) 9:20 - 10:05 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P56-1Pharmacology Establishment of medical care system for immune-related adverse events at Konan Kosei Hospital and its actual survey
[Speaker] Shigeto Tanemura:1 1:Department of pharmacy, Konan Kosei Hospital |
|
P56-2Pharmacology Collaboration between insurance pharmacy pharmacists and hospital pharmacists via oncology tracing reports
[Speaker] Kumi Nakamura:1 1:Aizawa Hospital |
|
P56-3Pharmacology Evaluation of chemotherapy side effects management system and future issues
[Speaker] Yoshihiro Yamanaka:1 1:Shizuoka Saiseikai General Hospital |
|
P56-4Pharmacology Evaluation of Closed-System drug Transfer Device (CSTD) for the Preparation and Administration of Hazardous Drugs, Report 1~Hazardous drug Leakage~
[Speaker] Setsuko Anami:1 1:Osaka breast clinic |
|
P56-5Pharmacology Evaluation of Closed-System drug Transfer Device (CSTD) for the Preparation and Administration of Hazardous Drugs, Report 2―Ease of Operation and Amount of Medical Waste―
[Speaker] Miyuki Sakurai:1 1:Department of Pharmacy, Kansai Rosai Hospital |
|
P56-6Pharmacology About the introduction of a closed-system drug Transfer Devise (Chemosafe-Lock™system) at our hospital
[Speaker] Masato Yokoyama:1 1:Shizuoka Saiseikai General Hospital |
ePoster 57
Breast (surgery, multimodal therapy)
October 21 (Sat) 10:30 - 11:20 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P57-1Breast (surgery, multimodal therapy) Study on the Prognostic Improvement Effect of Local Anesthetic Injection into the Peritumoral Region of Breast Cancer
[Speaker] Akira Matsui:1 1:Breast surgery, National Hospital Organization Tokyo Medical Center |
|
P57-2Breast (surgery, multimodal therapy) Locoregional surgery for de novo stage IV breast cancer was unsuccessful: A case report
[Speaker] Yuko Nakayama:1 1:First Department of Surgery, Faculty of Medicine, University of Yamanashi |
|
P57-3Breast (surgery, multimodal therapy) Efficacy of local resection and multidisciplinary treatment for advanced or recurrent breast cancer
[Speaker] Yoko Maekawa:1 1:Breast Surgery, Kobe medical center |
|
P57-4Breast (surgery, multimodal therapy) A case of locally advanced breast cancer with a different clinical diagnosis and pathological findings after neoadjuvant chemotherapy
[Speaker] Yoshika Nagata:1 1:Department of Surgery, Kokura Memorial Hospital |
|
P57-5Breast (surgery, multimodal therapy) Two cases of breast cancer with spontaneous regression caused by different mechanism
[Speaker] Naoki Ashizawa:1 1:First Department of Surgery, Hospital, University of Yamanashi |
|
P57-6Breast (surgery, multimodal therapy) A report on sentinel node biopsy of breast cancer using the Medical Imaging Projection System at our hospital
[Speaker] Takahiro Ichikawa:1 1:Department of Breast and Endocrine Surgery, Hospital, Nagoya University |
|
P57-7Breast (surgery, multimodal therapy) The effect of pembrolizumab around surgery for triple negative breast cancer
[Speaker] Masaru Hirata:1 1:Department of Breast Surgery, Nerima Hikarigaoka Hospital |
ePoster 58
Breast (drug)
October 21 (Sat) 11:20 - 12:10 ePoster Booth 2 | Pacifico Yokohama Exhibition Hall AB
|
P58-1Breast (drug) Case: Re-administration of Trastuzumab Deruxtecan after discontinuation due to interstitial lung disease in a patient with HER2-Positive Metastatic Breast Cancer
[Speaker] Takashige Tsuji:1 1:Breast Surgery, Shonankamakura General Hospital |
| P58-2Breast (drug) Withdrawn |
|
P58-3Breast (drug) Palbociclib with standard endocrine therapy in the primary and secondary treatment of hormone receptor-positive HER2-negative metastatic or recurrent breast cancer
[Speaker] Hidetaka Watanabe:1 1:Department of Surgery, Hospital, Kurume University |
|
P58-4Breast (drug) Postoperative adjuvant treatment using S-1 combined with endocrine therapy for patients with HR-positive and HER2-negative primary breast cancer
[Speaker] Rie Sugihara:1 1:Department of Surgery, School of Medicine, Kurume University |
|
P58-5Breast (drug) Endometrial cancer (EC) arising in a breast cancer patient during adjuvant treatment with tamoxifen (TAM)
[Speaker] Yasuyo Suzuki:1 1:Breast and tyhroid ward, Suzukake Central Hospital |
|
P58-6Breast (drug) A long-term stable disease under fulvestrant administration in a patient with metastatic breast cancer
[Speaker] Tatsuo Horie:1 1:Pharmacy, Oda municipal hospital |
|
P58-7Breast (drug) Experience of Scalp Cooling Therapy for Prevention of chemotherapy induced alopecia
[Speaker] Takatoshi Makino:1 1:Breast surgery, Yamagata Prefectural Central Hospital |
ePoster 59
Pancreas (surgery, multimodal therapy) 1
October 21 (Sat) 8:30 - 9:15 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P59-1Pancreas (surgery, multimodal therapy) Short-term outcomes of robotic distal pancreatectomy for pancreatic cancer
[Speaker] Go Shinke:1 1:Kansai Rosai Hospital |
|
P59-2Pancreas (surgery, multimodal therapy) Conversion Surgery for Unresectable Pancreatic Cancer
[Speaker] Takahito Hirai:1,2 1:Department of Hepato-Biliary-Pancreatic Surgery, Hyogo Medical University, Hyogo Medical University, 2:Department of Surgery Division of Gastroenterological & General Surgery, School of Medicine, Showa University |
|
P59-3Pancreas (surgery, multimodal therapy) Conversion surgery for unresectable pancreatic cancer
[Speaker] Tomohiro Yoshimura:1 1:Second Department of Surgery, Wakayama Medical University |
|
P59-4Pancreas (surgery, multimodal therapy) Impact of neoadjuvant-chemotherapy for pancreatic ductal adenocarcinoma with duodenal obstruction
[Speaker] Daisuke Shirai:1 1:Division of Hepato-Biliary-Pancreastic Surgery, Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University |
|
P59-5Pancreas (surgery, multimodal therapy) Surgery for pancreatic metastasis from renal cell carcinoma
[Speaker] Teijiro Hirashita:1 1:Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University |
|
P59-6Pancreas (surgery, multimodal therapy) The impact of polyglycolic acid sheet on the incidence of pancreatic fistula after distal pancreatectomy
[Speaker] Motonori Edanami:1 1:Department of Surgery, School of Medicine, Keio University |
ePoster 60
Pancreas (surgery, multimodal therapy) 2
October 21 (Sat) 9:20 - 9:55 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P60-1Pancreas (surgery, multimodal therapy) Low Pre-Alb and high DUPAN-2 are risk factors for non-resection after laparotomy and early recurrence after curative intent resection in R pancreatic cancer
[Speaker] Yoshifumi Morita:1,3 1:Department of Surgery, Hamamatsu University School of Medicine, 3:Division of surgical care, Morimachi, Hamamatsu University School of Medicine |
|
P60-2Pancreas (surgery, multimodal therapy) Perioperative chemotherapy in elderly pancreatic cancer
[Speaker] Yoshiyuki Sasaki:1 1:Gifu Municipal Hospital |
|
P60-3Pancreas (surgery, multimodal therapy) A Case of Locally Advanced Large Pancreatic Head Cancer with Long-Term Survival Treated with Radical Resection following Systemic Chemotherapy with Gemcitabine and S-1
[Speaker] Takuji Naka:1 1:Department of surgery, Yonago Medical Center |
|
P60-4Pancreas (surgery, multimodal therapy) A case of postoperative recurrence of pancreatic cancer with Tumor Mutation Burden High treated with pembrolizumab
[Speaker] Makoto Takeda:1 1:Department of Surgery, Faculty of Medicine, Hamamatsu University School of Medicine |
|
P60-5Pancreas (surgery, multimodal therapy) A case of pancreatic cancer postoperative recurrence that was controlled for 6 months by strict carbohydrate restriction
[Speaker] Takahiro Einama:1 1:Department of Surgery, National Defense Medical College |
ePoster 61
Liver (surgery, multimodal therapy) 1
October 21 (Sat) 10:30 - 11:05 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P61-1Liver (surgery, multimodal therapy) Experiences of three-dimensional conformal radiotherapy (3D-CRT) for intrahepatic cholangiocarcinoma
[Speaker] Akinori Asagi:1 1:Gastrointestinal medical oncology, National Hospital Organization Shikoku Cancer Center |
|
P61-2Liver (surgery, multimodal therapy) A case of 4th line chemotherapy with Pimitespib for recurrent gastrointestinal stromal tumor
[Speaker] Tadashi Bando:1 1:Surgery, Saiseikai Toyama Hospital |
|
P61-3Liver (surgery, multimodal therapy) A Case of HCC with Complete Tumor Necrosis by Bladder Cancer Chemotherapy
[Speaker] Riona Ito:1 1:Yokkaichi Municipal Hospital |
|
P61-4Liver (surgery, multimodal therapy) A case of robotic partial hepatectomy for giant hepatic cystadenocarcinoma
[Speaker] Akihiro Nishimura:1 1:Department of surgery, School of Medicine, Fujita Health University |
|
P61-5Liver (surgery, multimodal therapy) Validation of Risk Factors and Prognosis of Surgical Site Infection in Cancer Surgery Patients Using an Online PRO Information System
[Speaker] Tomohiro Ishinuki:1 1:Sapporo Medical University |
ePoster 62
Liver (surgery, multimodal therapy) 2
October 21 (Sat) 11:20 - 11:55 ePoster Booth 3 | Pacifico Yokohama Exhibition Hall AB
|
P62-1Liver (surgery, multimodal therapy) Utility of Beppu's nomogram in the patients with colorectal liver metastases treated with microwave coaglo-necrotic therapy
[Speaker] Yoshiyuki Wada:1 1:Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Kyushu Medical Center |
|
P62-2Liver (surgery, multimodal therapy) Laparoscopic hepatectomy for simultaneous liver metastasis of colorectal cancer
[Speaker] Yoshiaki Ohmura:1 1:Department of Surgery, Kansai Rosai Hospital |
|
P62-3Liver (surgery, multimodal therapy) Predictive factors for successful resection in simultaneously detected liver and lung metastases
[Speaker] Kazuhisa Takeda:1 1:Medical center, Yokohama City University |
|
P62-4Liver (surgery, multimodal therapy) A case of multiple metastatic liver tumors in the bilateral lobes performing two-stage hepatectomy
[Speaker] Shinya Ida:1 1:Department of Surgery, Hamamatsu University School of Medicine |
|
P62-5Liver (surgery, multimodal therapy) A Case of Resectable Advanced Hepatoblastoma Achieved by Intraoperative Navigation and Inferior Vena Cava Reconstruction
[Speaker] Nobuhiro Takahashi:1 1:Department of Pediatric Surgery, School of Medicine, Keio University |
International Poster 1
Supportive care・Breast
October 20 (Fri) 8:30 - 9:15 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
| IP1-1Supportive care・Breast Withdrawn |
|
IP1-2Supportive care・Breast Prognostic Significance of a Five-Factor Modified Frailty Index in Patients with Gastric Cancer Undergoing Curative-intent Resection
[Speaker] Wankyu Eo:1 1:Medical oncology/hematology, Internal Medicine, Kyung Hee University, Korea |
| IP1-3Supportive care・Breast Withdrawn |
| IP1-4Supportive care・Breast Withdrawn |
| IP1-5Supportive care・Breast Withdrawn |
| IP1-6Supportive care・Breast Withdrawn |
International Poster 2
Gynecology・Case
October 20 (Fri) 9:20 - 9:55 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
| IP2-1Gynecology・Case Withdrawn |
| IP2-2Gynecology・Case Withdrawn |
|
IP2-3Gynecology・Case Primary Synchronous Cancers of the Endometrium and Ovary:10- Year Treatment Experience
[Speaker] Shih-Tsung Chang:1,2 1:Institute of Medicine, Medical University of Chung Shan, Taiwan, 2:Women's Cancer Group, Dpartment of Radiation Oncology, Medical University of Chung Shan, Taiwan |
| IP2-4Gynecology・Case Withdrawn |
| IP2-5Gynecology・Case Withdrawn |
International Poster 3
Urology・Stomach・Colorectal
October 20 (Fri) 13:35 - 14:10 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
IP3-1Urology・Stomach・Colorectal KEYNOTE-905/EV-303:Phase 3 study of perioperative pembrolizumab(pembro)or pembrolizumab plus enfortumab vedotin(EV)for muscle-invasive bladder cancer(MIBC)
[Speaker] Andrea Necchi:1 1:Vita-Salute San Raffaele University;IRCCS San Raffaele Hospital and Scientific Institute, Italy |
|
IP3-2Urology・Stomach・Colorectal KEYNOTE-992:Phase 3 study of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for muscle-invasive bladder cancer(MIBC)
[Speaker] Yasuhisa Fujii:1 1:Tokyo Medical and Dental University |
|
IP3-3Urology・Stomach・Colorectal Low Gamma-butyrobetaine dioxygenase(BBOX1)as a prognostic biomarker in patients with Clear Renal Cell Carcinoma:Machine learning approach and drug discovery
[Speaker] Kyueng-Whan Min:1 1:Department of Pathology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Korea |
|
IP3-4Urology・Stomach・Colorectal Signet ring cell histology and its prognostic value in surgical treatment in gastric carcinoma
[Speaker] Dong Yi Kim:1 1:Surgery, Chonnam National University Medical School, Korea |
| IP3-5Urology・Stomach・Colorectal Withdrawn |
International Poster 4
Lung・Brain・Soft tissue
October 20 (Fri) 14:25 - 15:10 ePoster Booth 4 | Pacifico Yokohama Exhibition Hall AB
|
IP4-1Lung・Brain・Soft tissue Analysis of survival outcomes in patients with brain metastases secondary to non-small cell lung cancer:a single-center study of Thailand
[Speaker] Chaichana Chantharakhit:1 1:Division of Medical Oncology, Oncology Unit, Buddhasothorn Hospital, Thailand |
| IP4-2Lung・Brain・Soft tissue Withdrawn |
| IP4-3Lung・Brain・Soft tissue Withdrawn |
| IP4-4Lung・Brain・Soft tissue Withdrawn |
| IP4-5Lung・Brain・Soft tissue Withdrawn |
| IP4-6Lung・Brain・Soft tissue Withdrawn |


